about
Development of Companion DiagnosticsAdvancing biomedical imagingThe role of general nuclear medicine in breast cancerRadiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsAdvances in molecular imaging for breast cancer detection and characterizationRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingImaging of gastroenteropancreatic neuroendocrine tumorsMedical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)Multimodality and nanoparticles in medical imagingMolecular imaging: current status and emerging strategies.Developing Targeted Hybrid Imaging Probes by Chelator ScaffoldingSelection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersPeptides and peptide hormones for molecular imaging and disease diagnosisFactors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancersQuantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approachA steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo.The contribution of physics to Nuclear Medicine: physicians' perspective on future directions.Near-infrared molecular probes for in vivo imaging.Molecular theranostics: a primer for the imaging professionalOestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FESMeasuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.Molecular imaging as a tool for translating breast cancer sciencePhage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineAntibody vectors for imaging.Molecular and functional imaging of breast cancer.Biomarkers and imaging: physics and chemistry for noninvasive analyses.Non-FDG PET in oncology.Rationale for the use of radiolabelled peptides in diagnosis and therapy.Molecular imaging for personalized cancer care.Imaging agents for the chemokine receptor 4 (CXCR4).Radiolabeling strategies for tumor-targeting proteinaceous drugs.Molecular imaging in the era of personalized medicineScavenging strategy for specific activity improvement: application to a new CXCR4-specific cyclopentapeptide positron emission tomography tracer.A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.Investigation of cancer cell lines for peptide receptor-targeted drug development.Radiolabeled peptides: valuable tools for the detection and treatment of cancerExploring new frontiers in molecular imaging: Emergence of Ga PET/CT.99mTc-LHRH in tumor receptor imaging.Concurrent quantification of multiple nanoparticle bound states.
P2860
Q26774670-6EE731C2-9FF0-4D8C-9CAE-89F61DA48680Q26776383-F5AA738F-4350-48B8-936A-7536F9AE2AE3Q26801069-B578B13D-8E42-4544-8902-64507692131AQ26801806-B04AEA97-D7D1-4B76-9332-B80E2B2E702CQ27000462-081D0DD8-3D59-41EB-8BBA-3B70062A56C1Q28072021-1CC7E038-02D2-4F74-9653-CA2318904801Q28238305-FB80E582-0D40-408C-99C6-45BF94DE8335Q28651176-F652D184-51DD-424D-9E51-C8113AEF5C12Q30407070-CD62C6A4-3B24-4FA5-AA35-E07E7D284005Q30474579-82A6A0D9-85DD-4821-975E-4F0CD819F3BAQ33827092-07976102-D2E7-4B0A-B731-97EC4F32E873Q33832781-23B4C80F-2244-45C5-9AE2-BEF545EB341DQ33846924-B00BF81A-3C68-4D67-B965-41A218DA158EQ33939772-CA33DE16-B3E1-4F5C-A3F4-41320055FF1DQ34040411-764AA757-E0DB-4293-A568-62646CC23EEAQ34717908-06FC6FB0-65FA-44D8-A810-984EECAAF4F3Q35141461-25EAF00C-FE9B-4E3B-A947-7CA6CCA850F6Q35821199-42E0A382-1BAE-4E80-BDB4-A1E491827F0AQ35906695-B4FBEC62-1A31-4BBB-8418-AE6039345CEBQ36251545-F6C7E0DE-7244-4F28-B7C3-9B422EB553B0Q36326057-E529D718-39BD-4E08-8E0A-E0E4D6E86413Q36429530-CA35DF13-4396-45A6-9AA1-25FBE2A71ADFQ37019264-AFE6E717-0127-4DA2-AE68-3B11E033A113Q37644025-A2EB67C7-CF90-4B65-BDBC-9678047AA8DFQ37720850-401687C6-81AA-463A-B128-C7FBCEFAA9C5Q37776141-4FFE6F9C-ECD0-405A-9258-7558333AFD96Q37810197-6338EA7A-AB0D-47FB-B026-37AB690B4224Q37956045-519EC666-B9C1-482B-A707-137C3B178A4AQ37990410-8AF56AFB-A942-45F2-B6BB-2C5FF7C7AA27Q37999206-6395C0C8-D0CF-453D-826C-1DA2FB976DCEQ38022430-559283CF-2DF0-41F7-91E6-29337654760FQ38189541-C2195CF2-60FE-408E-B144-B51F638A3088Q38392168-90F6C8B3-6AB2-4513-9D5B-4D93558C33D2Q38959024-CDB8F479-4186-41C6-82EB-C07D64FB091DQ39284797-12FAE58E-A5C8-465C-8C2B-43FBC309201BQ39492350-1A530823-0370-4EB9-8372-D24A833DACF0Q39596344-A386285C-BEE4-457C-98EE-3F87A7DF8D86Q39805119-309A5DD7-D4D5-45F0-A1FE-06B52C83C2DFQ40979226-60348DB2-F8F0-4A88-B38D-677785C2C509Q41773287-9B9ED7D2-82CB-4E7B-9DE4-D7956413E116
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor receptor imaging.
@en
Tumor receptor imaging.
@nl
type
label
Tumor receptor imaging.
@en
Tumor receptor imaging.
@nl
prefLabel
Tumor receptor imaging.
@en
Tumor receptor imaging.
@nl
P2093
P1476
Tumor receptor imaging.
@en
P2093
David A Mankoff
Hannah M Linden
Jeanne M Link
Kenneth A Krohn
Lavanya Sundararajan
P304
P356
10.2967/JNUMED.107.045963
P407
P478
49 Suppl 2
P577
2008-06-01T00:00:00Z